GlassScriptPhysician profile
Samuel D Gerber
NPI 1669442737
$4,481.68
in general payments reported to CMS, 2019-2025
9 companies · $16.35 in 2025
The $16.35 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.00 · 2020: $2,625 · 2021: $43.55 · 2022: $159 · 2023: $155 · 2024: $1,432 · 2025: $16.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807 · Travel and Lodging: $453 · Consulting Fee: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.41 |
| Travel and Lodging | $453.00 |
| Consulting Fee | $343.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $2,625.00 | 2020 | |
| Medacta USA, INC. | $935.39 | 2024 | |
| Stryker Corporation | $382.96 | 2021-2024 | Triathlon, Mako |
| Hikma Pharmaceuticals USA | $343.50 | 2024 | Combogesic IV |
| Depuy Synthes Sales INC. | $77.61 | 2023 | Expressew, Truespan Orthocord |
| Pacira Therapeutics, INC. | $50.00 | 2019 | |
| Medical Device Business Services, INC. | $35.48 | 2023 | |
| Moximed, INC | $16.35 | 2025 | Misha Knee System, Small, Left |
| Pacira Pharmaceuticals Incorporated | $15.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.